# Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures

> **NCT00914927** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 130 (actual)

## Conditions studied

- Thrombocytopenia Related to Chronic Liver Disease

## Interventions

- **DRUG:** Avatrombopag
- **DRUG:** Avatrombopag
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00914927
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-11-11
- **Final completion:** 2011-12-21
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914927, "Once-Daily Oral Avatrombopag Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00914927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*